About GPE EXPO
Empowering Pharmaceutical Manufacturing Across Emerging Markets
Two Decades of Pharma Excellence
We've proven our ability to increase local manufacturing, attract FDI, and build pharma capabilities in emerging markets worldwide.
25+
Years of Excellence
Industry leadership since 1997
500+
Exhibitions Organized
Successfully organized globally
10+
Countries
Including India, Bangladesh, Kenya, Nigeria, Jordan
850+
Exhibitors Annually
At flagship Asia Pharma Expo
About GPE EXPO
GPE EXPO is a UAE-based global exhibition organizer dedicated to advancing the pharmaceutical manufacturing sector through international trade events. We connect innovation, technology, and opportunity, building specialized B2B platforms for industrial growth, investment partnerships, and knowledge exchange in developing and frontier markets.
Our expertise enables access to best-in-class technologies, raw materials, and manufacturing solutions to strengthen regional self-reliance and global competitiveness. We're committed to industry development and government collaboration, making every exhibition a catalyst for innovation, sustainable growth, and regional integration in the global pharmaceutical supply chain.
Connecting global technology providers with local manufacturers
Facilitating foreign direct investment in emerging pharma markets
Building regulatory compliance and quality standards
Technology Transfer
Connecting local manufacturers with global machinery, technology, and API suppliers.
Industry Investments
Facilitating crucial FDI inflows that accelerate pharma sector growth.
Capacity Building
Strengthening local production capabilities and elevating quality standards.
R&D & Innovation
Fostering collaboration through expert-led scientific seminars and knowledge exchange.
Flagship Exhibitions Organised by GPE EXPO
Our proven track record of successful pharmaceutical manufacturing exhibitions across continents.
Asia Pharma Expo
Largest pharmaceutical manufacturing exhibition in Bangladesh, attracting 850+ exhibitors annually.
Impact
Transformed Bangladesh pharma from import-dependent to 98% domestic production.
Nigeria Pharma Manufacturers Expo
Driving pharmaceutical investment and manufacturing growth across the West African region.
Impact
Catalyzed FDI and technology transfer across West Africa.
Arab Pharma Manufacturers Expo
Premier regional event emphasizing contract manufacturing and formulation development.
Impact
Enhanced regional pharmaceutical manufacturing capabilities.
East Africa Pharma Expo
Driving pharmaceutical investment and manufacturing growth across the East African region.
Impact
Strengthened East Africa pharmaceutical ecosystem.
Connecting Six High-Growth Pharma Markets of Central Asia
A Unified Platform for Central Asia's Pharmaceutical Growth
CaPhEx 2026 – Central Asia Pharma Expo serves as the strategic hub for pharmaceutical technology, investment, and industrial partnerships across six emerging Central Asian markets. Together, these countries represent a population of over 110 million and a collective pharmaceutical market exceeding USD 5 billion, yet remain largely import-dependent.
Region Overview
Uzbekistan
Kazakhstan
Kyrgyzstan
Tajikistan
Turkmenistan
AfghanistanThe expo provides the ideal gateway for global suppliers and investors to engage with a region now focused on self-reliance, modernization, and manufacturing growth.
Uzbekistan – The Regional Leader
Market Size
USD 2 billion (2024) with continued double-digit growth
Government Aim
80% localization of pharma production by 2027
- Over 200 manufacturing enterprises under the Pharmaceutical Industry Development Agency
- Attractive investment environment through Tashkent Pharma Park and Free Economic Zones (FEZs)
Strategic Opportunity
Uzbekistan leads Central Asia's industrial transformation with strong regulatory modernization, investment incentives, and government-backed GMP expansion programs.
Kazakhstan – A Diversified & Regulated Market
Market Size
Pharma market exceeds USD 1.1 billion, growing more than 20% in 2024
Key Players
Nobel AFF and SANTO (Polpharma Group)
- One of the region's largest and most industrially advanced economies
Strategic Opportunity
Growing demand for APIs, machinery, packaging, and process technologies to strengthen domestic manufacturing and meet international standards.
Kyrgyzstan – A Market Opening for Partnerships
Market Status
About 90% of medicines are imported
Growth Rate
Expected 6.5% CAGR (2021–2026)
- Regulatory improvements underway with WHO support for digital traceability and quality systems
Strategic Opportunity
A rising market ideal for suppliers of equipment, contract manufacturing, and quality-control solutions.
Tajikistan – Strengthening Generics & Local Production
Market Size
Market value approximately USD 87 million (2024)
Key Players
Sifat Pharma, Alpen Pharma
- Expanding demand for affordable generics and modern production technologies
Strategic Opportunity
Partnerships with local formulators, distributors, and investors to expand essential medicines manufacturing.
Turkmenistan – Rising Demand for Manufacturing Solutions
Market Size
Market value around USD 350 million (2024)
Import Status
Imports dominate, primarily from India and Europe
- Government prioritizing healthcare modernization and industrial self-sufficiency
Strategic Opportunity
High potential for turnkey plant setups, cleanroom systems, and formulation facilities supporting healthcare growth.
Afghanistan – Frontier Market Under Transition
Market Size
Estimated market near USD 1 billion, almost entirely import-dependent
Key Suppliers
Uzbekistan and Iran are key regional suppliers
- Ongoing initiatives to establish local packaging and formulation capacity
Strategic Opportunity
Expanding market for generics, APIs, and contract manufacturing collaborations, supported by regional trade integration.
💡 Why CaPhEx 2026?
CaPhEx 2026 is designed to connect technology providers, investors, and manufacturers to accelerate the growth of pharmaceutical manufacturing in Central Asia. The event enables:
Technology Transfer
Access to best-in-class equipment, raw materials, and global expertise.
Investment & Localization
Opportunities for joint ventures, contract manufacturing, and industrial expansion.
Government & Industry Integration
A platform for policy dialogues and cross-border collaboration on pharma regulation and production standards.
By exhibiting at CaPhEx 2026, companies gain direct access to all six markets through one strategic platform, engaging buyers, policymakers, and investors shaping the future of pharmaceutical manufacturing in Central Asia.
Exhibitor Profile
Discover the comprehensive range of pharmaceutical products, services, and solutions that will be showcased at CaPhEx 2026.
APIs & Excipients
Active pharmaceutical ingredients, excipients, and chemical raw materials.
Formulations & Contract Manufacturing
Finished dosage manufacturers, contract manufacturing services, and private-label production.
Processing & Packaging Machinery
Equipment for tablet/capsule production, filling, blistering, sterilization, and other processing needs.
Packaging Materials
Pharma-grade packaging solutions - foils, bottles, closures, labels, and serialization systems for track & trace.
Laboratory & Analytical Equipment (QA/QC)
Quality control labs, analytical instruments, validation and testing equipment ensuring GMP compliance.
Cleanroom & Utilities
Cleanroom infrastructure, HVAC systems, water purification, sterilizers, and other critical utilities for pharma facilities.
Biotech & Biosimilars
Biotechnology innovations, biosimilar development, and bioprocessing technologies relevant to emerging biologics in the region.
Turnkey Projects & Consulting
Turnkey project specialists, engineering consultants, and pharma industrial zone developers to support end-to-end facility setup.
Why Exhibit at CaPhEx 2026?
Join the premier pharmaceutical exhibition in Central Asia and unlock unprecedented opportunities across six emerging markets.
Reach Six Markets via One Expo
Save time and cost by meeting clients from all Central Asian countries in one venue. The region's pharma industry is rapidly expanding, with Kazakhstan's pharma sales topping 1,152.6 billion tenge in 2024.
Local companies are actively seeking suppliers and partners for production localization, making CaPhEx 2026 the perfect platform to connect with decision-makers from across the region.
High Demand, Untapped Opportunities
Local production covers only about 20% of demand in some countries, indicating Central Asia is largely untapped. Imported drugs dominate 80-90% of the market, creating significant opportunities for machinery, raw materials, and expertise.
Exhibit at CaPhEx to be at the forefront as regional firms aim to replace imports with local manufacturing.
Government & Buyer Engagement
Connect directly with qualified buyers and officials. Strong government endorsement brings expected delegations from health ministries and state pharma programs eager to meet technology providers.
Our B2B matchmaking program pre-schedules meetings with regional manufacturers, distributors, and investors to maximize lead generation and partnership opportunities.
Pan-Regional Brand Visibility
Establish your brand as a key player in Central Asia. Extensive media coverage and association partnerships promote exhibitors through press releases, catalogs, and seminars.
Gain first-mover advantage and extra visibility as a founding exhibitor in the inaugural edition of CaPhEx.
Why Visit CaPhEx 2026?
Your Gateway to Central Asia's Pharma Transformation
Your Gateway to Central Asia's Pharma Transformation
CaPhEx 2026 – Central Asia Pharma Expo is the region's most focused platform for professionals and organizations in the pharmaceutical manufacturing and allied industries.
📅 Event Details
Taking place on 27-28 October 2026 at Anhor Park Exhibition Area, Tashkent, Uzbekistan
The exhibition brings together technology providers, contract manufacturers, regulators, distributors, and R&D professionals under one roof. It offers a unique opportunity to discover, connect, and collaborate with the world's leading suppliers and innovators as Central Asia moves towards self-reliance and industrial growth in pharmaceuticals.
Who Should Visit
CaPhEx 2026 welcomes every key stakeholder from the pharmaceutical and healthcare manufacturing ecosystem. The exhibition is designed to bring together professionals who drive innovation, ensure compliance, and strengthen manufacturing capabilities across the region.
CEOs and Top Management
Decision-makers shaping business strategy and expansion.
Corporate & Operations Management
Professionals overseeing production efficiency and industrial growth.
Drug Regulatory Authorities
Officials involved in policy, licensing, and GMP compliance.
Manufacturing & Production Officers
Plant-level professionals responsible for formulation and process optimization.
Quality Assurance (QA), Quality Control (QC) & Research Teams
Experts ensuring safety, consistency, and innovation.
Pharmacists & Contract Manufacturers
Organizations engaged in formulation development and contract production.
Plant & Maintenance Engineers
Specialists in machinery operation, process utilities, and facility upgrades.
Vendor Development & Procurement Heads
Sourcing leaders managing raw materials, packaging, and technology purchases.
Compliance & Regulatory Professionals
Ensuring adherence to global quality and safety standards.
Warehousing & Supply Chain Managers
Overseeing logistics, storage, and pharmaceutical distribution.
Equipment & Machinery Manufacturers, Suppliers & Distributors
Companies catering to the region's expanding production infrastructure.
Drug Stores, API & Formulation Importers
Traders, wholesalers, and distribution channels connecting global supply with regional demand.
What You'll Experience
200+ Global Exhibitors
Meet technology leaders and solution providers from over 30 countries showcasing innovations across every stage of pharmaceutical manufacturing - from raw materials and process machinery to biotech, packaging, and utilities.
National & International Pavilions
Explore pavilions from India, China, Turkey, Europe, and CIS countries, featuring turnkey technologies and partnerships that can strengthen local manufacturing in Central Asia.
B2B Matchmaking & Investment Forum
Join structured business-to-business meetings and investment networking sessions connecting regional manufacturers with global suppliers, investors, and consultants.
Delegations & Knowledge Exchange
Interact with official delegations, government authorities, and regional associations to understand policy developments, industry regulations, and collaboration opportunities.
Industry Insights & Technology Demonstrations
Gain firsthand exposure to live product demos, process solutions, and case studies designed to help local manufacturers upgrade their operations and expand their production capacity.
Why You Should Attend
Discover the latest pharmaceutical technologies and innovations tailored for regional needs.
Learn from experts about GMP compliance, quality standards, and manufacturing excellence.
Connect directly with potential partners for contract manufacturing and supply agreements.
Explore investment-ready projects and government-supported industrial initiatives.
Be Part of the Growth Story – witness the evolution of Central Asia's pharmaceutical industry and its growing role in global healthcare manufacturing.
Exhibitor List
Stay tuned for the complete list of exhibitors participating in CaPhEx 2026.
Bangladesh Transformation
Our flagship Asia Pharma Expo transformed Bangladesh from an import-dependent market to a global pharmaceutical powerhouse. This success story demonstrates our proven ability to catalyze industry transformation.
Key Takeaway
“Bangladesh transformed into a self-sufficient, export-oriented pharma powerhouse. CaPhEx aims to replicate this success in Central Asia.”
Transformation Achievements:
Market size grew from USD 25 million (1982) to USD 3 billion (2024)
Projected to surpass USD 6 billion by 2025
Meeting 98% domestic medicine demand via local production
Exporting to 157 countries including USA, Germany, and UK
52.45% year-on-year export increase achieving USD 92.58 million
Multiple internationally accredited facilities (MHRA, USFDA, GMP-WHO, TGA)
Trusted Industry Authority
Led by visionary leadership with strategic alliances across the global pharmaceutical industry.
25+
Years Experience
10+
Countries Served
500+
Exhibitions